Time-Resolved Fluorescence Imaging and Correlative Cryo-Electron Tomography to Study Structural Changes of the HIV-1

Zaida K Rodriguez1,2, Jonathan R Andino-Moncada3, Sergey A Buth4

  • 1The Salk Institute for Biological Sciences, La Jolla, San Diego, California 92037, United States.

ACS Nano
|August 22, 2025
PubMed

Insights

A new correlative light and cryo-electron microscopy (CLEM) workflow enables detailed structural studies of human immunodeficiency virus type 1 (HIV-1) capsids. This method visualizes how antivirals like Lenacapavir stabilize HIV-1 capsid structures.

Area of Science:

  • Structural Biology
  • Virology
  • Microscopy

Background:

  • The human immunodeficiency virus type 1 (HIV-1) capsid is crucial for viral genome protection and cell infection.
  • Antivirals, including Lenacapavir (LEN), target HIV-1 replication by altering capsid structure and function.
  • Structural characterization of HIV-1 capsids, their disassembly, and antiviral-induced stabilization presents significant challenges.

Purpose of the Study:

  • To develop an improved correlative light and cryo-electron microscopy (CLEM) workflow for characterizing HIV-1 capsid morphology.
  • To enable precise structural analysis of HIV-1 capsids, including those treated with antivirals and cellular metabolites.
  • To facilitate in vitro studies on HIV-1 capsid stabilization and disassembly mechanisms.

Main Methods:

  • Development of a novel CLEM workflow integrating affinity capture of fluorescent HIV-1 particles on cryo-EM grids.
  • Implementation of streamlined alignment protocols for correlating fluorescence and cryo-electron tomography (cryo-ET) images.
  • Application of the CLEM workflow to analyze HIV-1 capsids treated with Lenacapavir (LEN) and inositol hexaphosphate (IP6).

Main Results:

  • A reproducible CLEM workflow was established for accurate capsid localization for cryo-ET.
  • Distinct modes of HIV-1 capsid lattice stabilization were resolved upon treatment with LEN and IP6.
  • The workflow demonstrated feasibility in correlating time-resolved fluorescence imaging of capsid disassembly with end-point cryo-ET structures.

Conclusions:

  • The developed CLEM workflow significantly advances in vitro structural studies of HIV-1 capsid stabilization and disassembly.
  • This methodology provides insights into the mechanisms of antiviral action on HIV-1 capsid structure.
  • The CLEM approach is adaptable for studying structural dynamics in other viruses under various conditions.